172 related articles for article (PubMed ID: 8239902)
21. Tumor tissue recycling--a new combination treatment for solid tumors: experimental and preliminary clinical research.
Li B; Ding J; Larson A; Song S
In Vivo; 1999; 13(5):433-8. PubMed ID: 10654199
[TBL] [Abstract][Full Text] [Related]
22. Effect of two antiproteinases on the growth of transplantable tumors and the proliferation of untransformed and transformed cells in culture.
Gavilondo J; Pérez R; Mainardi V; Lage A
Neoplasma; 1982; 29(3):315-22. PubMed ID: 6182475
[TBL] [Abstract][Full Text] [Related]
23. [The immunomodulator thymalin in the experimental chemotherapy of tumors].
Amosova EN; Iaremenko KV; Cherdyntseva NV; Nikolin VP; Ogreba VI
Vopr Onkol; 1987; 33(10):68-72. PubMed ID: 3686911
[TBL] [Abstract][Full Text] [Related]
24. Administration of subtumor regression dosage of TNF-alpha to mice with pre-existing parental tumors augments the vaccination effect of TNF gene-modified tumor through the induction of MHC class I molecule.
Lu Y; Yamauchi N; Koshita Y; Fujiwara H; Sato Y; Fujii S; Takahashi M; Sato T; Kato J; Yamagishi H; Niitsu Y
Gene Ther; 2001 Apr; 8(7):499-507. PubMed ID: 11319616
[TBL] [Abstract][Full Text] [Related]
25. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
26. Local and systemic antitumor response after combined therapy of mouse metastatic tumors with tumor cells expressing IFN-alpha and HSVtk: perspectives for the generation of cancer vaccines.
Santodonato L; D'Agostino G; Santini SM; Carlei D; Musiani P; Modesti A; Signorelli P; Belardelli F; Ferrantini M
Gene Ther; 1997 Nov; 4(11):1246-55. PubMed ID: 9425449
[TBL] [Abstract][Full Text] [Related]
27. Dendritic cells in antitumor immune responses. II. Dendritic cells grown from bone marrow precursors, but not mature DC from tumor-bearing mice, are effective antigen carriers in the therapy of established tumors.
Gabrilovich DI; Nadaf S; Corak J; Berzofsky JA; Carbone DP
Cell Immunol; 1996 May; 170(1):111-9. PubMed ID: 8665591
[TBL] [Abstract][Full Text] [Related]
28. Preliminary observations on the effect of glucan in combination with radiation and chemotherapy in four murine tumors.
Stewart CC; Valeriote FA; Perez CA
Cancer Treat Rep; 1978 Nov; 62(11):1867-72. PubMed ID: 728904
[TBL] [Abstract][Full Text] [Related]
29. Antitumor protection using murine dendritic cells pulsed with acid-eluted peptides from in vivo grown tumors of different immunogenicities.
Ribas A; Bui LA; Butterfield LH; Vollmer CM; Jilani SM; Dissette VB; Glaspy JA; McBride WH; Economou JS
Anticancer Res; 1999; 19(2A):1165-70. PubMed ID: 10368670
[TBL] [Abstract][Full Text] [Related]
30. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
[TBL] [Abstract][Full Text] [Related]
31. Marked antiangiogenic and antitumor efficacy of AG3340 in chemoresistant human non-small cell lung cancer tumors: single agent and combination chemotherapy studies.
Shalinsky DR; Brekken J; Zou H; Bloom LA; McDermott CD; Zook S; Varki NM; Appelt K
Clin Cancer Res; 1999 Jul; 5(7):1905-17. PubMed ID: 10430098
[TBL] [Abstract][Full Text] [Related]
32. Combination chemotherapy and IL-15 administration induce permanent tumor regression in a mouse lung tumor model: NK and T cell-mediated effects antagonized by B cells.
Chapoval AI; Fuller JA; Kremlev SG; Kamdar SJ; Evans R
J Immunol; 1998 Dec; 161(12):6977-84. PubMed ID: 9862733
[TBL] [Abstract][Full Text] [Related]
33. Use of protamine to augment adenovirus-mediated cancer gene therapy.
Lanuti M; Kouri CE; Force S; Chang M; Amin K; Xu K; Blair I; Kaiser L; Albelda S
Gene Ther; 1999 Sep; 6(9):1600-10. PubMed ID: 10490770
[TBL] [Abstract][Full Text] [Related]
34. Early macrophage and cytokine response during the growth of immunogenic and non-immunogenic murine tumors.
Kisseleva E; Becker M; Lemm M; Fichtner I
Anticancer Res; 2001; 21(5):3477-84. PubMed ID: 11848512
[TBL] [Abstract][Full Text] [Related]
35. Transplantable IgD immunoglobulin-secreting tumors in rat.
Bazin H; Beckers A; Urbain-Vansanten G; Pauwels R; Bruyns C; Tilkin AF; Platteau B; Urbain J
J Immunol; 1978 Nov; 121(5):2077-82. PubMed ID: 712079
[TBL] [Abstract][Full Text] [Related]
36. Non-H-2 restriction specificity of tumor-regressor mouse sera with regard to their activity to inhibit tumor cell transplantation.
Egawa K; Kiyohara T; Tanino T
Jpn J Exp Med; 1982 Oct; 52(5):255-60. PubMed ID: 7169670
[TBL] [Abstract][Full Text] [Related]
37. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.
Utsugi T; Shibata J; Sugimoto Y; Aoyagi K; Wierzba K; Kobunai T; Terada T; Oh-hara T; Tsuruo T; Yamada Y
Cancer Res; 1996 Jun; 56(12):2809-14. PubMed ID: 8665518
[TBL] [Abstract][Full Text] [Related]
38. Hexamethylmelamine-induced regression of human lung tumors growing in immune deprived mice.
Mitchley BC; Clarke SA; Connors TA; Neville AM
Cancer Res; 1975 Apr; 35(4):1099-102. PubMed ID: 1116144
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
[TBL] [Abstract][Full Text] [Related]
40. 5-Aminolevulinic acid photodynamic therapy of transplantable colon adenocarcinoma in BALB/c mice.
Ziółkowski P; Symonowicz K; Osiecka BJ; Rabczyński J
Arch Immunol Ther Exp (Warsz); 1998; 46(5):301-4. PubMed ID: 9832069
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
